Call Today: (800) 791-5856
Submit your Levaquin claim details for a free, no obligation case review
Get Started:
To date, the Food and Drug Administration (FDA) has yet to issue a national recall of Levaquin, the oral and injectable antibiotic prescribed to treat serious bacterial infections. In July 2008, the FDA did announce that Ortho-McNeil-Jassen, the manufacturer of Levaquin, was now required to print “black box” warnings on all Levaquin packaging.
Black box warnings, the most serious level of FDA warnings that precede an actual recall, indicate that a drug may cause some irreversible, severe and/or potentially fatal side effects.
Patients who are injured after taking Levaquin, as well as families of deceased Levaquin patients, will likely:
Injured patients should seek legal counsel from an experienced defective drug attorney who will determine if they have a legitimate and claim and qualify to seek compensation for their losses.
Prescribed in the U.S. for over 13 years, Levaquin is classified as a “fluoroquinolone antiinfective durg” and has been used in the treatment of a number of bacterial infections, including (not limited to):
Unfortunately, Levaquin also has the potential to cause a range of side effects, including (not limited to):
Patients who sustain any severe Levaquin side effects will require emergency medical attention and, in most cases, long-term care to save their lives.
If you’ve suffered an adverse side effect after taking Levaquin, contact a Levaquin lawyer today for legal help.
A class of antibiotics known as fluoroquinolones needs heightened warnings about the risk of tendon rupture and tendonitis, said the U.S. Food and Drug Administration on Tuesday.
Fluoroquinolone antibiotics include:
Copyright © 2001 - 2009 Online Lawyer Source | Legal Marketing Site Designed by eJustice